• europages
  • >
  • COMPANIES - SUPPLIERS - SERVICE PROVIDERS
  • >
  • biopharmaceutical products

Results for

Biopharmaceutical products - Manufacturer Producer - United Kingdom

United KingdomManufacturer/producer
  1. AMITYCHEM CORPORATION

    United Kingdom

    Amitychem Corporation was formed in 2007 as an alternative to the major suppliers in the chemical industry so customers could receive quality as well as competitive costs. From the beginning, Amitychem Corporation offered API, intermediate and specialty chemicals. Amitychem Corporation has their own plant, R&D lab, office and warehouse in China, bringing the most competitive price, the fastest delivery and the highest quality API available for maximum repeatability in the most difficult shades. In addition, Amitychem Corporation has individuals with years of sourcing experience who have visited the manufacturing facilities throughout the world. Technical staff with API production experience along with marketing executives round out the team. In 2011, Amitychem Corporation started to specialize in fine intermediate chemicals. This greatly enhanced the product variety of Amitychem Corporationso it could serve many additional industries. In 2015, Amitychem Corporation invested into petroleum industry, tried the field of petroleum chemicals and rapidly succeeded. Amitychem Corporation offers a full line of products to fit the needs of today’s highly responsive market whether that be for APIs, fine intermediates, biocides, cosmetics, inks, dyes, coatings, plastic resins, petroleum products, etc.

  2. SEKISUI DIAGNOSTICS UK

    United Kingdom

    BioProduction by Sekisui offers contract development and manufacturing services for the biopharmaceutical industry. Formerly part of Genzyme, our facility in the UK has over 40 years of large-scale fermentation and purification experience. We have process and analytical development capabilities for enzymes, plasmids, antibody fragments and other proteins. We offer GLP, ISO 13485 and GMP manufacturing.

  3. POWDER SYSTEMS LIMITED (PSL)

    United Kingdom

    PSL is an award-winning international manufacturer providing quality innovative technology with process development expertise to the pharmaceutical, biopharmaceutical, chemical and laboratory industries since 1989. We are regarded as pioneering designers and engineers of advanced containment processes for highly potent and valuable products, from laboratory R&D to production-scale process systems. Our solutions provide innovative technologies, enabling pharmaceutical manufacturers to bring new-generation drugs into the marketplace faster. PSL is proud to be improving patients’ lives all around the world.

  4. ND PHARMA & BIOTECH

    United Kingdom

    The ND Pharma & Biotech Company is a Biopharmaceutical, Biotechnological and Global Chemical Company proudly operating worldwide. Our operations include a variety of sectors and fields from Healthcare and Medical Sciences to Life Sciences, Food and Nutrition, Agrochemicals, Industrials, an Pharmaceutical, Cosmetic and General Chemicals, Research, Innovation, Laboratory, etc. With a portfolio of over 182.000 product references, we are a leader in the sector. Over 500 IP/PI rights granted in different areas from Drug Discovery to Novel Therapies for unmet medical needs. A section of +2.000 rare and ultra-rare molecules under management. Business Development Office is quite active and looking constantly for new business partners and associates worldwide. We are a family- owned, financially stable and management-agile company with less or no bureaucracy in management and decision taking.

  5. EMERGENT PRODUCT DEVELOPMENT GERMANY GMBH

    United Kingdom

    Emergent BioSolutions is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, which are a subset of products that are known as biologics. Immunobiotics are biologics that induce or assist the body? s immune system to prevent or treat disease, consisting of vaccines and certain therapeutic products, including immune globulins. We operate in two business segments: biodefense and commercial. In our biodefense business, we develop, manufacture and commercialize immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. In our commercial business, we develop immunobiotics for use against infectious disease. Our commercial immunobiotic product candidates are designed to address significant unmet or underserved public health needs.